About ABIRAPRON ABIRATERONE ACETATE TABLETS
Abirapro 250 Mg Abiraterone Acetate
Specifications :-
- Brand Name : Abirapro
- Active Ingredients : Abiraterone Acetate
- Manufactured by : Glenmark
- Strength : 250 mg
- Packing: Pack of 120 Tablets
Note:-Abirapro is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug...........
Targeted Therapy for Prostate CancerAbirapron is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. Through the action of Abiraterone Acetate, this medication helps inhibit androgen biosynthesis, thereby slowing the progression of prostate tumors and supporting comprehensive cancer care.
Strict Prescribing and Usage GuidelinesAs a prescription-only medication, Abirapron must be administered under medical supervision. Each 250 mg tablet is designed for oral intake, with dosage tailored individually by a qualified physician. Adhering to prescribed guidelines ensures optimal efficacy and minimizes side effects such as fatigue or increased blood pressure.
Safe Handling and Storage ProtocolsAbirapron must be stored below 30C and kept away from moisture to preserve its shelf life and potency. The bottle packaging contains 120 tablets, providing both convenience and protection, ideal for distributors and healthcare providers while ensuring patient safety throughout its usage period.
FAQs of ABIRAPRON ABIRATERONE ACETATE TABLETS:
Q: How should Abirapron tablets be taken for optimal results?
A: Abirapron tablets must be swallowed whole with water, following the dosage schedule prescribed by your physician. The medication should not be chewed or crushed, and taking it at the same time each day is recommended to maintain consistent therapeutic levels.
Q: What is Abirapron used for and who can take it?
A: Abirapron is intended for the treatment of adults diagnosed with metastatic castration-resistant prostate cancer (mCRPC). Its active ingredient, Abiraterone Acetate, is formulated to inhibit androgen production, helping slow disease progression in eligible patients.
Q: When is the best time to start Abirapron therapy?
A: Abirapron therapy should be initiated as soon as a physician prescribes it for a patient diagnosed with mCRPC. Early intervention, as advised by your healthcare provider, can improve treatment outcomes and overall prognosis.
Q: Where should Abirapron be stored to maintain its quality?
A: Abirapron should be stored below 30C in a dry environment, away from moisture and direct sunlight. Proper storage in its original bottle ensures the medicine remains effective throughout its 24-month shelf life.
Q: What steps should be followed before exporting or distributing Abirapron?
A: Before exporting or distributing Abirapron, ensure all regulatory approvals and documentation are in place. Verify batch integrity, packaging quality, and compliance with storage guidelines to guarantee safe delivery and usage.
Q: What are the potential side effects of Abirapron usage?
A: Common side effects of Abirapron include fatigue, joint swelling, and increased blood pressure. Patients should report unusual symptoms to their physician promptly for assessment and supportive care.
Q: How does Abirapron benefit patients with prostate cancer?
A: Abirapron offers the benefit of targeted androgen inhibition, helping control prostate cancer progression. This contributes to better disease management, enhanced quality of life, and extended survival for eligible adults.